LBTD (Lotus Bio-Technology Development) Change In Receivables: $0.00 Mil (TTM As of Dec. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lotus Bio-Technology Development Change In Receivables?

Lotus Bio-Technology Development LBTD -99.99% Change In Receivables is $0.00 Mil as of Dec. 2017.

Lotus Bio-Technology Development's change in receivables for the quarter that ended in Dec. 2017 was $0.00 Mil. It means Lotus Bio-Technology Development's Accounts Receivable stayed the same from Sep. 2017 to Dec. 2017 .

Lotus Bio-Technology Development's change in receivables for the fiscal year that ended in Mar. 2017 was $0.00 Mil. It means Lotus Bio-Technology Development's Accounts Receivable stayed the same from Mar. 2016 to Mar. 2017 .

Lotus Bio-Technology Development's Accounts Receivable for the quarter that ended in Dec. 2017 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lotus Bio-Technology Development's liquidation value for the three months ended in Dec. 2017 was $-0.07 Mil.

Lotus Bio-Technology Development  (OTCPK:LBTD) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Lotus Bio-Technology Development's Days Sales Outstanding for the quarter that ended in Dec. 2017 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, Lotus Bio-Technology Development's accounts receivable are only considered to be worth 75% of book value:

Lotus Bio-Technology Development's liquidation value for the quarter that ended in Dec. 2017 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.05-0.117+0.75 * 0+0.5 * 0
=-0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Change In Receivables Related Terms

Lotus Bio-Technology Development Change In Receivables Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Change In Receivables Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Change In Receivables
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lotus Bio-Technology Development Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.00 Mil mean?
Lotus Bio-Technology Development (LBTD) has a Change In Receivables of $0.00 Mil as of Dec. 2017. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's Change In Receivables too high?
Lotus Bio-Technology Development's current Change In Receivables is $0.00 Mil.
How does Lotus Bio-Technology Development's Change In Receivables compare to SNES and CVAT?
Lotus Bio-Technology Development's Change In Receivables of $0.00 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Agriculture company?
A good Change In Receivables depends on the Agriculture industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Lotus Bio-Technology Development and its competitors. Lotus Bio-Technology Development's current Change In Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current Change In Receivables of $0.00 Mil. The current Change In Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current Change In Receivables is $0.00 Mil as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.